Identification of a Retinoic Acid Receptor Alpha Subtype Specific Agonist
Overview
Authors
Affiliations
Recent advances in the design of RAR α and RAR β agonists as orally bioavailable drugs. A review.
Borthwick A, Goncalves M, Corcoran J Bioorg Med Chem. 2020; 28(20):115664.
PMID: 33069074 PMC: 7588594. DOI: 10.1016/j.bmc.2020.115664.
Haffez H, Chisholm D, Valentine R, Pohl E, Redfern C, Whiting A Medchemcomm. 2018; 8(3):578-592.
PMID: 30108774 PMC: 6072416. DOI: 10.1039/c6md00680a.
Clarke E, Jarvis C, Goncalves M, Kalindjian S, Adams D, Brown J Bioorg Med Chem. 2017; 26(4):798-814.
PMID: 29288071 PMC: 5823845. DOI: 10.1016/j.bmc.2017.12.015.
Brown G, Marchwicka A, Cunningham A, Toellner K, Marcinkowska E Arch Immunol Ther Exp (Warsz). 2016; 65(1):69-81.
PMID: 27412076 PMC: 5274652. DOI: 10.1007/s00005-016-0411-0.
Retinoic acid actions through mammalian nuclear receptors.
Huang P, Chandra V, Rastinejad F Chem Rev. 2013; 114(1):233-54.
PMID: 24308533 PMC: 3931982. DOI: 10.1021/cr400161b.